Skip to main content
Caplight Logo









AFFiRiS AG

AFFiRiS AG

Private
ViennaHealthcare & Life Scienceshttps://affiris.com/

Last Round

Series B

May 2, 2017

Total Funding Raised

$21.18M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AFFiRiS AG is a biotechnology company that develops specific active immunotherapies for the treatment of chronic neurodegenerative and cardiometabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

specific active immunotherapySAITpeptide vaccinetherapeutic vaccineclinical-stage biotechPCSK9 inhibitorhypercholesterolemia treatmentdrug licensingout-licensingimmunotherapymonoclonal antibodyHuntington's disease treatmentmAbssynthetic peptidesdisease-modifying treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AFFiRiS AG Comparables

Compare AFFiRiS AG with similar companies based on industry and business-model similarity.

AFFiRiS AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vaxxinity, Inc.
78%
3H Bio
71%
Wave Life Sciences
69%

AFFiRiS AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 2, 2017
VC RoundJun 23, 2016
VC RoundJun 16, 2015
Series AApr 6, 2006

AFFiRiS AG Investors

Notable investors and investment history

AFFiRiS AG investors
InvestorRounds
MIG FondsSeries A
Santo Holding AGSeries B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 146% MoM, reaching 1.8K.

  • Oct 29, 2024

    Monthly visitors increased 42% MoM.

AFFiRiS AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AFFiRiS AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AFFiRiS AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range2
Year Founded2003
Last FundingMay 2, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?